New drugs to fight TB, especially its drug-resistant forms, are urgently needed.

Most TB/HIV deaths can be averted if TB and HIV services work together more effectively and services are scaled up.

The declaration spells out the universal values, principles and demands that guide civil society advocacy efforts towards the goal of zero TB deaths.

New MSF multinational study of paediatric TB/HIV co-infection confirms crisis of undiagnosed TB among children.

The use of new technologies and approaches to actively seek out people with tuberculosis can significantly increase the number of people diagnosed and put on treatment.

Médecins Sans Frontières data results reveal urgent need to scale up drug-resistant tuberculosis treatment.

Some 100 TB activists marched through the Kuala Lumpur Convention Centre, demanding more ambitious targets for stopping TB, the funding to meet those targets and an end to the use of detrimental language in the TB community.

Treatment Action Group and the Stop TB Partnership issue update on 2011 global TB R&D investment trends; 2011 funding increases 3% to US$649.6 million, but annual US$1.35 billion funding gap remains.

ACTION has released its second brief on children and TB, issuing recommendations for the international community and affected countries to combat this neglected epidemic.